Follow the 아미코젠 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Chemicals sector, 아미코젠 has logged 68 insider filings. The latest transaction was filed on 3 March 2026 (Purchase). Among the most active insiders: 신용철. Every trade is openly available.
68
Insider Decl.
n/a
Thresholds
n/a
34 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Amicogen is a company specializing in the chemistry and materials sector, listed on the XKRX market. It focuses on the development of biotechnological and enzymatic solutions.